News
In July 2006, the FDA warned that concomitant use of a triptan (5-hydroxytryptamine [5-HT; serotonin] receptor agonists) and a selective 5-HT reuptake inhibitor (SSRI) or selective 5-HT/norepinephrine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback